Procter & Gamble
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Procter & Gamble's revenues will wither -1.0% and EPS will grow 0.9%.
The average estimate for revenue is $21.92 billion. On the bottom line, the average EPS estimate is $1.11.
Last quarter, Procter & Gamble booked revenue of $20.74 billion. GAAP reported sales were 3.7% lower than the prior-year quarter's $21.53 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.06. GAAP EPS of $0.96 for Q1 were 6.8% lower than the prior-year quarter's $1.03 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 50.7%, 90 basis points better than the prior-year quarter. Operating margin was 20.8%, 110 basis points better than the prior-year quarter. Net margin was 13.6%, 40 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $84.27 billion. The average EPS estimate is $3.96.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 7,418 members out of 7,663 rating the stock outperform, and 245 members rating it underperform. Among 1,969 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 1,934 give Procter & Gamble a green thumbs-up, and 35 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Procter & Gamble is outperform, with an average price target of $69.98.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Procter & Gamble. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Procter & Gamble to My Watchlist.